June 17, 2020 / 12:42 PM / a month ago

BRIEF-PDS Biotechnology And Farmacore Biotechnology To Co-Develop PDS0204 Covid-19 Vaccine

June 17 (Reuters) - PDS Biotechnology Corp:

* PDS BIOTECHNOLOGY AND FARMACORE BIOTECHNOLOGY ANNOUNCE CO-DEVELOPMENT OF PDS0204 COVID-19 VACCINE

* PDS BIOTECHNOLOGY CORP - CO, FARMACORE WILL ACCELERATE DEVELOPMENT OF VERSAMUNE COV-2FC INTO PHASE 1 CLINICAL TESTING IN BRAZIL

* PDS BIOTECHNOLOGY CORP - FARMACORE RETAINS COMMERCIALIZATION RIGHTS IN LATIN AMERICA, ON VERSAMUNE -COV-2FC

* PDS BIOTECHNOLOGY CORP - REVENUE FROM LATIN AMERICA SALES WILL BE SHARED BETWEEN COS ON VERSAMUNE -COV-2F

* PDS BIOTECHNOLOGY CORP - RETAINS RIGHT OF FIRST REFUSAL FOR COMMERCIALIZATION OUTSIDE OF LATIN AMERICA ON VERSAMUNE-COV-2FC

* PDS BIOTECHNOLOGY CORP - IS IN DISCUSSIONS WITH OTHER GOVERNMENTAL AND NON-GOVERNMENTAL AGENCIES REGARDING ADDITIONAL FUNDING FOR A COVID-19 VACCINE

* PDS BIOTECHNOLOGY CORP - INITIAL FINANCIAL SUPPORT PROVIDED BY BRAZILIAN MCTIC FOR DEVELOPMENT OF VERSAMUNE -COV-2FC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below